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We aimed to establish whether morphologic parameters were prognostically important in a large series of breast phyllodes tumors in Asian women. Of 335 phyllodes tumors diagnosed at the Department of
Phyllodes tumors of the breast are fibroepithelial neoplasms that have the potential for recurrence. [1] [2] [3] [4] [5] Grading (or classifying) into benign, borderline, and malignant categories is based on a constellation of histologic characteristics that includes the degree of stromal hypercellularity, stromal cytologic atypia and mitotic activity, stromal overgrowth, and circumscribed vs permeative margins. 6 Although histologic features have been helpful to some extent in predicting biologic behavior, specific parameters that can define the likelihood for recurrence are not universally accepted. 2 Various investigators have found grade, 7, 8 stromal overgrowth, 9,10 tumor necrosis and heterologous stromal elements, 11 or a combination of histologic features 12 to be prognostically useful. On the other hand, several authors have concluded that adequacy of surgical margins is of paramount importance 5, 6, [12] [13] [14] and that histologic factors have an inconsistent influence on biologic behavior.
Such studies have revolved mostly around limited numbers of cases, with the largest series to date detailed by Zurrida et al, 5 in which 216 women with phyllodes tumors were evaluated. We document the clinicopathologic features of what we believe is the largest series in the literature to date, of 335 Singapore women with breast phyllodes tumors diagnosed at the Department of Pathology, Singapore General Hospital. We revisit the role of histologic factors and explore their relationship with recurrent disease.
tumor diagnosed between January 1992 and December 2002. Patient details and tumor laterality were determined from accession forms. Tumor size and macroscopic findings of hemorrhage, myxoid, or necrotic changes and of cystic degeneration were obtained from surgical pathology reports.
Histologic slides were retrieved and reviewed. Core criteria used for the diagnosis of phyllodes tumor were prominent fronds or leaf-like pattern and increased stromal cellularity, 15 and these formed the basis for distinction from fibroadenoma, a related pathologic entity without this specific combination of histologic features.
Classification into benign, borderline, and malignant categories relied on the degree of stromal hypercellularity, cytologic atypia, mitotic activity, stromal overgrowth, and nature of the borders (circumscribed vs permeative). 6 A circumscribed border was characterized by a pushing margin that protruded or bulged against the surrounding breast tissue; a permeative border was one in which extensions of tumor crept into adjacent tissue without a well-defined interface between tumor and nonlesional tissue ❚Image 1A❚ and ❚Image 1B❚. Stromal hypercellularity and cytologic atypia were categorized as mild, moderate, or severe. Stromal mitotic activity was quantified per 10 high-power fields (hpf) of the microscope objective (40× objective and 10× eyepiece, 0.196 mm 2 ) in the most mitotically active areas of the stroma. Stromal overgrowth, defined as a low-power field (4× microscope objective and 10× eyepiece, 19.64 mm 2 ) that comprised only stroma without epithelial elements, 16 was deemed absent or present.
A benign phyllodes tumor was diagnosed when the lesion showed pushing margins, mild or moderate stromal hypercellularity, mild or moderate stromal cytologic atypia, occasional mitoses that numbered up to 4/10 hpf, and no stromal overgrowth. A malignant tumor was defined by marked stromal hypercellularity and cytologic atypia, presence of stromal overgrowth, brisk mitotic activity (≥10/10 hpf), and permeative margins; the finding of a malignant heterologous element placed the tumor into a malignant category. Borderline phyllodes tumor showed some but not all characteristics observed in malignant lesions.
In addition, the degree of epithelial hyperplasia (mild, moderate, or severe), the presence or absence of epithelial metaplasia, pseudoangiomatous stromal hyperplasia (PASH) within the tumor, histologic infarction, necrosis, and hemorrhage were evaluated. PASH was deemed present when at least 1 low-power field within the tumor revealed characteristic slit-like spaces within the stroma. Infarction was distinguished from histologic tumor necrosis by the finding of karyorrhectic particles in the latter, whereas infarction was typified by ghost cell outlines but with generally preserved architecture. The presence of heterologous stromal elements was documented, with typical phyllodes tumor areas together with absence of an observable malignant epithelial component making the distinction from metaplastic carcinoma.
Adjacent breast tissue in the sections was reviewed for significant histologic alterations: atypical ductal and lobular hyperplasia and lobular and ductal carcinoma in situ. Coexistent fibroadenomas were documented.
The surgical procedure was defined from the accession forms or case notes or deduced from macroscopic descriptions in the pathology report. The women underwent 3 main forms of surgical treatment: excisional biopsy, wide excision, or mastectomy. Surgical margins, based on available histologic material, were evaluated as complete when sections sampled showed a surrounding rim of nonlesional breast tissue, focally involved
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❚Image 1❚ Phyllodes tumor with a circumscribed (pushing) border (A, H&E, ×40) contrasted with a tumor with a permeative margin (B, H&E, ×40).
when tumor extended in only 1 focus to the inked or cauterized surgical margin, or diffusely involved when the surgical margin was breached by tumor in more than 1 focus. In women who underwent further follow-up surgery, surgical margin status was assessed in the latter pathologic specimen. Adjuvant radiation or chemotherapy was not part of the treatment. Patient follow-up was derived from case notes and the Singapore Cancer Registry, National Disease Registries Office.
Statistical Analysis
Statistical analysis was carried out using SPSS for Windows, release 11.5 (SPSS, Chicago, IL). Recurrences were correlated with clinicopathologic parameters using the χ 2 test. The Mann-Whitney U test was used to compare means between variables. The recurrence-free survival and overall survival (OS) periods were calculated from the dates of pathologic diagnosis to the dates of documented histologic recurrence and death, respectively. Survival time was available for only 206 cases, which were used in the univariate and multivariate survival analyses. For statistical reasons, owing to the small numbers in some categories, the variables of tumor grade (benign, borderline, malignant) and margin status (complete, focal involvement, diffuse involvement) were compressed to 2 categories each of benign vs borderline or malignant and complete vs focal or diffuse involvement. Univariate survival curves were plotted using the KaplanMeier method, and statistical differences were determined by using the log-rank test. A P value of less than .05 was considered significant. Multivariate analysis was accomplished using the stepwise Cox proportional hazards model.
Results
Patients
A total of 335 women were diagnosed with phyllodes tumor during the study period. Their ages ranged from 16 
Pathologic Findings
The right and left breasts were affected in 168 (50.1%) and 165 (49.3%) cases, respectively; 2 women (0.6%) had bilateral tumors. The microscopic features of the bilateral tumors were almost identical in each case: in one case, the right and left benign tumors differed only in size (4 and 6 cm), mitotic rate (1 and 4 mitoses per 10 hpf), and surgical margin status (complete excision vs focal involvement); in the other case, the bilateral benign tumors also differed only in size (right, 2.5 cm; left, 2.2 cm) and epithelial hyperplasia (mild vs none). For statistical analysis, the tumors from the right breast were used.
Tumor size for the series ranged from 0.9 to 25 cm (mean, 5.4 cm; median, 4 cm). The size range for benign, borderline, and malignant tumors was 0.9 to 20 cm (mean, 4.3 cm), 1.2 to 22 cm (mean, 8.1 cm), and 2 to 25 cm (mean, 9.2 cm), respectively.
Gross description characterized 278 tumors (83.0%) as circumscribed and 20 (6.0%) as poorly circumscribed; the nature of the margins was not documented in the surgical pathology reports for the remaining 37 cases (11.0%). Cystic degeneration was noted macroscopically in 48 tumors (14.3%) and was absent in 286 (85.4%); information was not available in 1 case (0.3%). Necrosis was noted during gross examination in 13 tumors (3.9%) and was not evident in 321 cases (95.8%); necrosis was not mentioned in 1 case (0.3%). Macroscopic hemorrhage was documented in 38 tumors (11.3%) and was considered absent in 296 cases (88.4%); it was not documented in 1 case (0.3%). Ulceration of the overlying skin was present in 3 cases: 2 malignant phyllodes tumors, 1 measuring 17 cm and 1 measuring 16.5 cm, and a 19-cm borderline tumor.
The number of microscopic slides reviewed for each case ranged from 1 to 25 (mean, 6 sections; median, 5 sections). Histologic classification revealed 250 benign (74.6%), 54 borderline (16.1%), and 31 malignant (9.3%) phyllodes tumors. In 3 cases (0.9%) that were multifocal in the same breast, the histologic characteristics of the dominant or main or largest lesion in each case were used in data analysis. Histologic variability was observed in many lesions, and definitive phyllodes features occasionally were focal within the tumors. Mitotic activity ranged from nil to 80 mitoses per 10 hpf (mean, 4.45/10 hpf; median, 2/10 hpf), with mean mitotic rates of 1.91, 7.59, and 19.52 mitoses per 10 hpf for benign, borderline, and malignant tumors, respectively. There were 31 (9.3%) cases with stromal multinucleated giant cells, numbering from 1 to 52 such cells per 10 hpf, with mean values of 0.60, 3.59, and 6.76 per 10 hpf in benign, borderline, and malignant tumors, respectively. These tended to cluster in patchy aggregates.
PASH was present within the tumor in 245 cases (73.1%) and absent in 90 (26.9%) ❚Image 2❚. The majority of cases (292 [87.2%]) showed myxoid degeneration; it was not observed in the remainder (43 [12.8%]). Hemorrhage was observed histologically in 265 lesions (79.1%). Infarction was noted in 68 cases (20.3%). In 13 cases (3.9%), tumor necrosis was present. Vascular invasion was noted in 3 malignant phyllodes tumors (0.9%) ❚Image 3❚. Stromal metaplasia was observed in 11 cases (3.3%). These included benign adipose (1 case) and chondromyxoid (1 case) elements in 2 cases diagnosed as benign and borderline phyllodes tumor, respectively; the remainder represented malignant heterologous components (liposarcoma, 5 cases; chondroid and osteoid components, 1 case; osteosarcoma, 2 cases; rhabdomyosarcoma and liposarcoma, 1 case) in malignant phyllodes tumors.
In 87 (26.0%) of 334 cases, there was no hyperplasia in the epithelial elements of the phyllodes tumor, whereas 122 (36.5%), 94 (28.1%), and 31 (9.3%) tumors had mild, moderate, and severe epithelial hyperplasia, respectively. One case of malignant phyllodes tumor (0.03%) showed ductal carcinoma in situ (DCIS) of its epithelial component ❚Image 4A❚ and ❚Image 4B❚. Leafy fronds characteristic of phyllodes tumor were observed in most parts of the tumor. Atypical ductal hyperplasia was diagnosed in 5 cases (1.5%) and atypical lobular hyperplasia and lobular carcinoma in situ in 1 case (0.03%) each. Epithelial squamous metaplasia was observed in 12 cases (3.6%), 5 of which revealed squamous cysts.
Significant histologic alterations in the adjacent breast tissue included DCIS in 1 case (0.03%) and atypical ductal hyperplasia and atypical lobular hyperplasia in 3 cases each ❚Image 2❚ Pseudoangiomatous stromal hyperplasia in a benign phyllodes tumor with slit-like spaces lined by flattened cells (H&E, ×200).
❚Image 3❚ Vascular tumor embolus in a malignant phyllodes tumor featuring a plug of neoplastic stroma within a distended vascular space just beyond the periphery of the tumor (H&E, ×40).
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❚Image 4❚ Ductal carcinoma in situ (A, H&E, ×100), intermediate to high nuclear grade, with necrosis affecting the epithelial elements of a malignant phyllodes tumor (B, H&E, ×200).
(0.9%). One benign phyllodes tumor had cytoplasmic hyaline globules in the stromal cells. In 14 women (4.2%), synchronous fibroadenomas were removed concurrently with the phyllodes tumor. These were ipsilateral and contralateral in 5 and 9 cases, respectively.
Surgical treatment consisted of excisional biopsy in the majority of women (272 [81.2%]); 39 (11.6%), and 23 (6.9%) underwent wide excision and mastectomy, respectively. In 1 case (0.3%), the operative procedure was not known. Surgical margins were involved focally in 186 (55.7%) of 334 cases, diffusely affected in 9 cases (2.7%), and considered complete in the remaining 139 cases (41.6%). Margin status was associated significantly with grade, type of surgical procedure, and tumor size (P = .003, P < .001, P = .001, respectively); malignant and larger tumors and those subjected to mastectomy were more likely to have negative surgical margins.
❚Table 1❚ details the correlation of macroscopic and microscopic features with the grade of phyllodes tumor. Histologic parameters (stromal hypercellularity, cytologic atypia, mitoses, stromal overgrowth, and nature of the borders) used in the determination of grade were not included in this analysis. Recurrence and Survival A total of 43 women (12.8%) were documented histologically to have 57 recurrences during the follow-up period (mean and median follow-up periods, 30.3 and 20.4 months, respectively). In ❚Table 2❚, the relationship between clinicopathologic parameters and onset of first local recurrence is given. Ethnicity and laterality were not associated with recurrent disease. ❚Table 3❚ shows the grade progression of recurrent cases. Of 43 women who experienced recurrence, 9 (21%) had a second recurrence; 4 (9%) a third recurrence, and 1 (2%) a fourth recurrence. All were local recurrences, except in 2 cases (5% of women with recurrent disease) of malignant disease: 1 woman had spinal metastasis and 1 suffered lung metastasis during their third and second recurrent episodes, respectively ❚Image 5❚. Histologically, the metastases were composed of only malignant stromal elements; no epithelial component was identified. Two locally recurrent tumors showed invasion of skeletal muscle of the chest wall.
Among the recurrences, the majority (36/57 [63%], Table  3 ) were of the same grade. Upgrading to the next category was observed in 14 (25%). It was unusual that 6 recurrences were downgraded (11%): 2 originally borderline phyllodes tumors recurred as histologically benign tumors, 2 originally malignant cases recurred as benign lesions, and 2 malignant tumors recurred as microscopically borderline lesions, 1 each during the third and fourth recurrent episodes.
❚Table 4❚ details the clinicopathologic features of the 9 women (2.7%) who died during the follow-up period. Of note, all but 1 had a malignant phyllodes tumor at initial diagnosis. The cause of death was malignant disease in 7 women (mean and median survival, 31.6 and 17.0 months, respectively); 1 woman with a benign phyllodes tumor died of carcinoma of unknown origin, and 1 with a malignant phyllodes tumor died of acute myocardial infarction. Metastatic disease preceded death from phyllodes tumor in all cases. When stratified according to grade, the recurrence-free survival curves for benign (mean, 103.3 months) and borderline or malignant (mean, 89.4 months) tumors showed a difference that was not statistically significant (P = .21; curves not shown). In the OS curves ❚Figure 1❚, women with benign phyllodes tumor survived for a mean of 142 months, whereas those with malignant lesions survived for mean and median periods of 87 and 112 months, respectively (P < .01). No deaths occurred among the borderline cases. The sharp drop for the OS curve represented by benign phyllodes tumor was due to 1 death in this group from cancer of unknown origin.
In multivariate Cox analysis using stepwise regression, the presence of PASH (P = .028) and complete margins (P = .033) showed significant prognostic information ❚Figure 2A❚ and ❚Figure 2B❚. The risk of recurrence was reduced by 51.3% in women whose tumors included PASH compared with those without PASH (relative risk, 0.487; 95% confidence interval, 0.25-0.94). Similarly, women with complete margins had a reduced risk of 51.7% for developing recurrence compared with those with focal or diffusely involved margins (relative risk, 0.483; 95% confidence interval, 0.25-0.92). Although higher tumor grade was associated with an increased hazard of 1.63, it was not significant (P = .28). Histologic features of stromal atypia, stromal hypercellularity, and microscopic margins, which were associated significantly with recurrence when tested individually, were not significant in multivariate analysis.
Discussion
Phyllodes tumor of the breast first was characterized as a distinct entity by Johannes Muller in 1838, using the term cystosarcoma phyllodes. [17] [18] [19] The use of cystosarcoma to describe this lesion was not intended to connote malignancy but rather to reflect its cystic and fleshy appearance; in fact, a benign nature was implied in the original account. 18 Since then, there have been many reports on this fascinating entity, and apart from phyllodes tumor being the current universally adopted term that has replaced cystosarcoma phyllodes, multiple studies to identify histologic parameters that predict biologic behavior have yielded variable results. 11 Despite extended historic existence of phyllodes tumor of the breast, classification is still not ideal; there is difficulty distinguishing it from fibroadenoma at the benign end of the spectrum and problems subdividing into the 3 recognized grades of phyllodes tumors. There also is a small proportion of benign fibroepithelial neoplasms that histologically do not fit snugly into the category of fibroadenoma or phyllodes tumor.
The need to separate benign phyllodes tumor from fibroadenoma traditionally has been related to the recurrent and progressive potential of the former contrasted with the innocuous nature of the latter. The relationship between these 2 entities, however, is not understood fully. Early reports documented the presence of areas of fibroadenoma within otherwise characteristic phyllodes tumors 15, 17, 19 and alluded to fibroadenoma being the possible precursor or progenitor of phyllodes tumor. More recently, molecular evidence for the progression of fibroadenoma to phyllodes tumor was described, 3, 4 with Kuijper et al 3 expressing that fibroadenomas might progress not only in a stromal manner into phyllodes tumor, but also in an epithelial direction toward carcinoma in situ. Because areas of fibroadenoma are not encountered uncommonly in phyllodes tumors, adequate macroscopic sampling is required for excision specimens to avoid overlooking areas typical of phyllodes tumors, which might be very focal within the tumor. It also is noted that fibroadenomas can occur synchronously with phyllodes tumors, 19 as in 4.2% of the cases in our study. Although there are recommended criteria to guide classification, the interpretation of individual histologic parameters and their integration into a decision about benign, borderline, and malignant categories are still somewhat subjective. 11 Many authors have used the degree of stromal hypercellularity and atypia, mitotic rate, stromal overgrowth, and nature of microscopic margins as the histologic features to stratify phyllodes tumors into the grades of benign, borderline (the term indeterminate was used for this category by Chaney et al 9 ) , and malignant phyllodes tumor. 8, 9, 11, 14 The presence of necrosis also was taken into account by Moffat et al 6 and Reinfuss et al, 8 whereas Pietruszka and Barnes 12 incorporated stromal overgrowth into their primary definition of phyllodes tumor.
Others have subdivided phyllodes tumor into benign and malignant and further categorized the malignant group into low and high grades, essentially still resulting in a 3-tiered classification, 7, 20 with low-grade malignant and borderline lesions being synonymous.
Among the individual histologic parameters used in classification, there is clear variability in interpretation and cutoffs. For example, Kleer et al 14 regarded benign phyllodes tumors as those with fewer than 1 mitosis per 10 hpf, Rosen 20 allowed up to 2, Pietruszka and Barnes 12 used 0 to 4, and Moffat et al 6 accepted a figure of fewer than 10 mitoses per 10 hpf. In the present study, we used a cutoff of up to 4 mitoses per 10 hpf for benign phyllodes tumor. In addition to the discrepancy in cutoffs for mitotic activity, grading of the degree of stromal hypercellularity and atypia also is subject to interobserver inconsistency. Perhaps the histologic factors that have a more readily reproducible quality are stromal overgrowth, in which the definition proposed by Ward and Evans 16 is fairly standard, and margin quality, in which microscopic circumscription vs permeation can be ascertained more consistently.
With the system used in the present study, grade showed a significant correlation with recurrent disease (P = .028), with contributions from degree of stromal atypia (P = .016), stromal hypercellularity (P = .046), and nature of the microscopic borders (P = .021). Mitotic activity was not a statistically significant factor for predicting potential for recurrence (P = .184), similar to that found by Keelan et al. 2 Our findings indicate that although a final assigned grade of phyllodes tumor based on a constellation of histologic features is important to gauge behavior, the details of individual microscopic parameters should be provided in the surgical pathology report. Grade, however, did not retain its statistical significance in multivariate analysis.
Other than the histologic features used in grading phyllodes tumors, additional clinicopathologic parameters were ❚Image 5❚ Metastatic disease to the lung in a transbronchial lung biopsy specimen obtained from a woman with recurrence featuring malignant stroma (left field) devoid of epithelial elements effacing the pulmonary alveolar architecture (H&E, ×100).
associated significantly with tumor grade. Older age correlated with borderline and malignant phyllodes tumors, as did larger tumors. Macroscopic features that were useful in predicting a worse grade were poorly circumscribed margins, cystic degeneration, necrosis, and hemorrhage. Interestingly, intratumoral PASH and epithelial hyperplasia were correlated significantly with tumor grade. PASH is believed to be hormonally related, 21 and its more frequent observation in benign as opposed to malignant phyllodes tumors might be hypothesized by the stromal cells retaining their hormonal responsiveness in the former, whereas they have become autonomous, in keeping with malignancy, in the latter. The practical usefulness of this observation is that the finding of PASH in a phyllodes tumor is less likely to be associated with malignancy.
Likewise, epithelial hyperplasia diminished with worsening tumor grade, an observation noted previously by Pietruszka and Barnes. 12 Epithelial-stromal interactions in phyllodes tumors have been discussed by Sawhney et al 22 and Sawyer et al. 23, 24 In the earlier study, Sawhney et al 22 noted that mitotic activity tended to occur close to the epithelial elements, suggesting that stromal growth was dependent on the epithelium, whereas Sawyer et al 23 found distinct molecular alterations in the epithelial and stromal components of phyllodes tumors that indicated both elements likely participated in the neoplastic process, with further evidence of a relationship lent by an association between stromal nuclear β-catenin with epithelial Wnt5a expression. 24 It was believed that progression to malignancy in phyllodes tumors occurred with independence of the stroma from the epithelium. The inverse correlation between epithelial hyperplasia and phyllodes tumor grade in our study suggests that actively proliferating epithelium AMI, acute myocardial infarction; C, Chinese; CT, computed tomographic scan; hpf, high-power fields; M, Malay; PT, phyllodes tumor. * All tumors were malignant with permeative borders and marked stromal hypercellularity except in case 9, which involved a benign tumor with pushing borders and mild stromal hypercellularity. † Age at diagnosis. ‡ Clinicoradiologic evidence of skeletal muscle and rib involvement before surgery. tended to be associated with stromal and, hence, phyllodes tumor benignity, whereas malignancy in phyllodes tumors was seen in conjunction with quiescent epithelium. 26 found no correlation between the number of multinucleated stromal giant cells and phyllodes tumor grade and no evidence that these multinucleated cells were different from the usual stromal cells in phyllodes tumors. In the present study, the number of such cells correlated with phyllodes tumor grade but not with recurrence.
Cumulative
The presence of infarction or tumor necrosis correlated with grade and recurrence. We endeavored to distinguish infarction, which essentially represents ischemic necrosis with outstripping of vascular supply in large lesions, from tumor necrosis, in which high cell turnover, likely with apoptotic participation, occurs in concert with an underlying vascular cause. In the present study, tumor necrosis was observed most frequently in malignant phyllodes tumors. Although it was found to be an independent prognostic factor by CohnCedermark et al, 11 we were unable to reproduce this finding in our cases. Microscopic hemorrhage was noted more frequently in borderline and malignant cases, whereas the presence of myxoid change did not correlate with phyllodes tumor grade.
Other microscopic features observed in our cases that have been reported previously include squamous metaplasia, 20 malignant heterologous elements, and intracytoplasmic inclusion bodies in stromal cells, which are thought to be related to cytoplasmic microfilaments. 27 Recurrent disease occurred in 25 (10%), 11 (20%), and 7 (23%) cases of benign, borderline, and malignant phyllodes tumor, respectively, in the present study. Borderline and malignant tumors recurred within a shorter period, and these women also experienced diminished OS. As in other studies, 6,13,14,28 involvement of surgical margins was a key predictor of local recurrence and was independently significant in multivariate analysis, with clear or complete margins associated with a reduction in recurrent risk of 51.7%. Although the retrospective nature of the study might have limited the rigorousness of surgical margin evaluation, we thought that tumor sampling generally was adequate, with cases represented by fewer available slides or blocks for histologic review corresponding to the smaller tumors. Despite the correlation ❚Figure 2❚ Multivariate Cox analysis using stepwise regression. A, The presence of pseudoangiomatous stromal hyperplasia showed a significantly reduced likelihood of recurrence (P = .028; log-rank significance = .011). B, Likewise, for margin status, women with complete removal of tumors were significantly less likely to experience recurrence than those with focal or diffuse margin involvement (inv) (P = .033; log-rank significance = .041).
between surgical margin status and type of surgical procedure, the latter was not a significant factor in recurrence, implying that it is the actual margin clearance rather than the operative procedure per se that is important. It is noteworthy that negative margin status was encountered more frequently with larger and malignant tumors, possibly reflecting a more aggressive surgical approach to these tumors. The association of intratumoral PASH with a reduced likelihood of recurrence has not been reported previously, likely because the significance of its presence has not been addressed specifically by other investigators. The true usefulness of PASH as a prognostic morphologic parameter requires further scrutiny and validation. Apart from our earlier allusion to stromal hormonal responsiveness in phyllodes tumors with PASH, there may be other unclarified epithelial-stromal interactions in such lesions that affect clinical behavior.
The histologic downgrading of 6 recurrent tumors is unusual. A likely explanation is insufficient sampling of recurrent lesions in this retrospective series. It also can be extrapolated that grade, although correlated with recurrent disease in univariate analysis, is finally not an independent determinant of subsequent clinical behavior.
It is noteworthy that all deaths from disease occurred in women with malignant phyllodes tumors at initial diagnosis, underscoring the need to treat this group of women more aggressively at the outset, before recurrence and death occur. Local recurrences also occurred before the diagnosis of distant metastasis (mostly radiologically confirmed), which preceded death.
The promise of molecular science has led to a continued search for adjunctive biologic markers that can predict the behavior of phyllodes tumors. Proliferative activity using MIB-1 and S-phase fraction, 29, 30 microvessel density, 31 and CD34 and factor XIIIa stromal positivity 32 are believed to be potentially helpful. Perhaps the most studied is p53, 1, 28, 29, 33, 34 with some authors suggesting that it might be of prognostic value, 28, 29, 33 whereas its prognostic usefulness has not been affirmed by others. 1, 34 More recent work has found stromal overexpression of c-myc and c-kit to be associated with malignant phyllodes tumor. 35 To our knowledge, this study represents the largest series to date in the experience of a single institution with breast phyllodes tumors. Our ability to accrue this substantial number of cases is likely because our department has the largest surgical pathology service load in the country, with a very active breast surgical team. A higher incidence of phyllodes tumors among younger Asian women has been suggested. 20, 36 In an earlier Singapore study of 40 women from another institution, 37 60% were younger than 40 years, and it was considered that younger age at diagnosis might pose a problem in accurate preoperative diagnosis. We did not find a particularly young cohort among the 335 cases studied, with 42.4% younger than 40 years. During the same period of the study, 1992 to 2002, 4,842 cases of breast carcinoma were diagnosed at our department, making the incidence of phyllodes tumor 6.92% of all epithelial breast cancers. This percentage is higher than the 0.5% to 1.5% reported 6, 9 and might reflect a truly greater frequency of this tumor among Asian women. Revisiting clinicopathologic parameters reveals that careful and thorough appraisal of light microscopic morphologic findings remains important in the evaluation of breast phyllodes tumors, with histologic grade together with constituent elements of stromal atypia, microscopic borders, and stromal hypercellularity being correlated with recurrence, whereas intratumoral PASH and surgical margin status are independently prognostic in multivariate analysis.
